Literature DB >> 15723651

Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis.

Naohiro Sekiguchi1, Yukio Kobayashi, Yukiko Yokota, Shigeru Kusumoto, Kazuki Tanimoto, Takashi Watanabe, Yoshihiro Matsuno, Kensei Tobinai.   

Abstract

The frequency of t(14;18) in follicular lymphoma (FL) in Japan has been reported to be low compared to North America and other European countries. Recently, it has also been reported that FL lacks t(14;18), mainly among histological grade 3b, and occasionally has a rearranged Bcl-6 gene. It is not known whether a difference in histology or immunostaining pattern exists between FL with and without t(14;18). We performed interphase fluorescence in situ hybridization (FISH) analysis to detect Bcl-2/IgH, Bcl-6 gene rearrangement, Bcl-2 gene amplification, and the cyclinD1/IgH gene in formalin-fixed paraffin embedded specimens from our FL archives. The correlation between morphological features, histological grades, immunohistochemical findings, and cytogenetical aberrations was studied. In total, we found that 28 of 47 cases (59.6%) had t(14;18). Bcl-6 gene rearrangement and extra Bcl-2 gene signals were found in five and two cases, respectively. Only one had cyclinD1/IgH fusion. Ten of 12 grade 1, nine of 17 grade 2, and 0 of two grade 3 cases had fusion signals, respectively. None of the above abnormalities were detected in 12 of 47 cases (25.5%). Our data confirmed a high frequency of t(14;18) in FL in grade 1, but a lower incidence among grade 2, that could be attributed to the lower incidence of the translocation in FL in Japan. Immunostaining of both Bcl-2 and CD10 was highly predictable for the presence of t(14;18); the positive predictive value was 75%, suggesting the usefulness of the staining.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723651     DOI: 10.1111/j.1349-7006.2005.00014.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  10 in total

1.  Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo.

Authors:  S Ackler; M J Mitten; J Chen; J Clarin; K Foster; S Jin; D C Phillips; S Schlessinger; B Wang; J D Leverson; E R Boghaert
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocation.

Authors:  Naohiro Sekiguchi; Takashi Watanabe; Yukio Kobayashi; Chiho Inokuchi; Sung-Won Kim; Yukiko Yokota; Kazuki Tanimoto; Yoshihiro Matsuno; Kensei Tobinai
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

3.  Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up.

Authors:  Hiroyuki Kitabatake; Tadanobu Nagaya; Naoki Tanaka; Hiroyoshi Ota; Kenji Sano; Naoko Asano; Tomoaki Suga; Yoshiyuki Nakamura; Taiji Akamatsu; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2016-11-21

4.  Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.

Authors:  Dai Maruyama; Takashi Watanabe; Akiko Miyagi Maeshima; Junko Nomoto; Hirokazu Taniguchi; Teruhisa Azuma; Masakazu Mori; Wataru Munakata; Sung-Won Kim; Yukio Kobayashi; Yoshihiro Matsuno; Kensei Tobinai
Journal:  Int J Hematol       Date:  2010-12-01       Impact factor: 2.490

5.  Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study.

Authors:  Cindy M Chang; Jane C Schroeder; Wen-Yi Huang; Cherie H Dunphy; Ralph S Baric; Andrew F Olshan; Kathleen C Dorsey; Georgette A Dent; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair
Journal:  Leuk Res       Date:  2009-06-07       Impact factor: 3.156

6.  Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization.

Authors:  Dakeun Lee; Jinwon Seo; YoungLyun Oh; Jinman Kim; YoungHyeh Ko
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

7.  Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma.

Authors:  Kazuki Tanimoto; Naohiro Sekiguchi; Yukiko Yokota; Akihiro Kaneko; Takashi Watanabe; Akiko Miyagi Maeshima; Yoshihiro Matsuno; Mine Harada; Kensei Tobinai; Yukio Kobayashi
Journal:  BMC Cancer       Date:  2006-10-20       Impact factor: 4.430

8.  Clearance of systemic hematologic tumors by venetoclax (Abt-199) and navitoclax.

Authors:  Scott Ackler; Anatol Oleksijew; Jun Chen; Brenda J Chyla; Jerry Clarin; Kelly Foster; Thomas McGonigal; Sasmita Mishra; Sally Schlessinger; Morey L Smith; Stephen K Tahir; Joel D Leverson; Andrew J Souers; Erwin R Boghaert; Jonathan Hickson
Journal:  Pharmacol Res Perspect       Date:  2015-09-01

Review 9.  A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.

Authors:  Faroogh Marofi; Heshu Sulaiman Rahman; Muhammad Harun Achmad; Klunko Nataliya Sergeevna; Wanich Suksatan; Walid Kamal Abdelbasset; Maria Vladimirovna Mikhailova; Navid Shomali; Mahboubeh Yazdanifar; Ali Hassanzadeh; Majid Ahmadi; Roza Motavalli; Yashwant Pathak; Sepideh Izadi; Mostafa Jarahian
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

10.  Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups.

Authors:  Fen Zhang; Li-Xu Yan; Su-Xia Lin; Zi-Yin Ye; Heng-Guo Zhuang; Jing-Ping Yun; Han-Liang Lin; Dong-Lan Luo; Fang-Ping Xu; Xin-Lan Luo; Jie Cheng; Ke-Ping Zhang; Yan-Hui Liu
Journal:  Diagn Pathol       Date:  2013-09-18       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.